Intelligence Platform
Patents
Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6599744
Viral expression vectors comprising a ribosomal promoter sequence
expired patentUS 6596268
Viruses for the treatment of cellular proliferative disorders
expired patentUS 6589531
Recombinant yellow fever virus and method of use thereof
expired patentUS 6586392
Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
expired patentUS 6586419
Phototherapeutic inactivation of ocular viruses
expired patentUS 6579674
Method for selective inactivation of viral replication
expired patentUS 6576234
Reovirus for the treatment of neoplasia
expired patentUS 6572864
Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepat
expired patentUS 6573247
Anti-viral pyrimidine nucleoside analogues
expired patentUS 6573058
Antibody to herpes virus entry receptor protein
expired patentUS 6565831
Methods for preventing reovirus recognition for the treatment of cellular proliferative di
expired patentUS 6566093
Alphavirus cDNA vectors
expired patentUS 6565853
Recombinant virus
expired patentUS 6562376
DNA vaccines against poxviruses
expired patentUS 6558676
Parvovirus capsids
expired patentUS 6555367
Complex of biotinylated viral vector and ligand for targeted gene delivery
expired patentUS 6548068
Enhanced immune response to an antigen by a composition of a recombinant virus expressing
expired patentUS 6544757
Synthesis of human virus antigens by yeast
expired patentUS 6541483
Acridone-derived compounds useful as antineoplastic and antiretroviral agents
expired patentUS 6537557
Attenuated dengue-4 virus vaccine
expired patentUS 6528065
Attenuated dengue-3 virus vaccine
expired patentUS 6528305
Method of producing infectious reovirus
expired patentUS 6517842
Marburg virus vaccines
expired patentUS 6514501
Recombinant vaccine against dengue virus
expired